NCT06102824
- Conditions
- Advanced Breast Cancer, HER2-negative Breast Cancer
- Locations
-
- Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
Clinical trial condition
Advanced Breast Cancer
Explore clinical trials studying Advanced Breast Cancer. Study availability and eligibility vary by location and protocol.
170 public trials
63 recruiting studies
Advanced Breast Cancer trial results
NCT06044623
- Conditions
- Advanced Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
- Locations
-
- Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki Helsinki, Finland
- Fourth Oncology Department & Comprehensive Clinical Trials Center, Metropolitan Hospital Athens, Greece
- Second Department of Medical Oncology, Hygeia Hospital Athens, Greece
- Division of Oncology, Department of Medicine, University Hospital, University of Patras Medical School Pátrai, Greece
NCT06656624
- Conditions
- Advanced Breast Cancer
- Locations
-
- Jiangsu Provincial People's Hospital Nanjing, Jiangsu, China
NCT05594095
- Conditions
- Advanced Breast Cancer, Breast Cancer, Breast Diseases, +8 more
- Locations
-
- Breast cancer institute of Fudan University Cancer Hospital Shanghai, Shanghai Municipality, China
- Conditions
- Advanced Breast Cancer, HR Low/HER2 Negative, Treatment
- Locations
-
- Henan Breast Cancer Center, The Affiliated Cancer Hospital of Zhengzhou University Zhengzhou, Henan, China
Recruiting
Current Status of Treatment for Chinese Patients With ESR1-mutated HR+/HER2-advanced Breast Cancer
NCT06548919
- Conditions
- Advanced Breast Cancer, ESR1 Gene Mutation
- Locations
-
- Tianjin Haidafu Internet Hospital Suzhou, Jiangsu, China
NCT06544577
- Conditions
- Advanced Breast Cancer, ESR1 Gene Mutation, Safety
- Locations
-
- Hainan Hospital of Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine (Boao Research Hospital, Hainan) Qionghai, Hainan, China
NCT03577197
- Conditions
- Advanced Breast Cancer, Breast Diseases, Breast Neoplasms, +9 more
- Locations
-
- Multiple hospitals in the Netherlands (see Eligibility) Maastricht, Netherlands
Recruiting
Apatinib Combined With cdk4/6i in First-line Treatment for HR+/HER2- SNF4 Subtype Breast Cancer
NCT06447623
- Conditions
- Advanced Breast Cancer, HR+/HER2- Breast Cancer
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
- Conditions
- Advanced Breast Cancer, Breast Cancer Metastatic, HER2 Low Breast Carcinoma, +1 more
- Locations
-
- Gustave Roussy Institut Villejuif, France